If you believe you were not adequately informed about the severe risks, such as gastroparesis or gallbladder disease, before starting the medication, you might have a valid claim
Evolving CMS Policy on Anti-Obesity Medications Historically, Medicare Part D excluded coverage for weight loss drugs under a statutory provision allowing Medicaid programs to do the same
You can request a referral to bariatric medicine specialists who may have more flexibility, or explore telehealth options outside Kaiser (though you'd pay out of pocket)
The mechanism operates primarily through butyrate production, which acts on receptors that can stimulate GLP-1 secretionthough the magnitude of this effect in humans and whether it translates to meaningful appetite suppression remains unclear
The two component drugs also have FDA approval for other purposes and are available as inexpensive generic medications, so they can be prescribed separately and taken together